ROBINS HARLAN S
Chief Scientific Officer
ROBINS HARLAN S has filed 11 SEC Form 4 filings (20 transaction rows) across 1 company, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Jul 23, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$29.6M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| ADPT | Chief Scientific Officer | Sale | 492,400 | $10.8M | Jul 23 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 386,240 | $8.5M | Jul 7 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 100,000 | $1.7M | Jun 17 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 6,160 | $111K | Jun 17 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 10,000 | $149K | Apr 10 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 470,266 | $6.2M | Mar 13 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 10,000 | $157K | Mar 4 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 14,233 | $235K | Mar 4 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 34,668 | $645K | Feb 4 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 8,120 | $154K | Feb 4 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 10,000 | $164K | Jan 8 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 27,212 | $506K | Dec 5 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 10,000 | $166K | Dec 5 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 10,000 | $148K | Nov 12 | SEC ↗ |